Verruca (Warts) Completed Phase 2 Trials for Resiquimod (DB06530)

Back to Verruca (Warts)

Also known as: Verruca / Verruca, Warts / Warts / Wart / Other viral warts / Verruca vulgaris / Common wart / Viral warts / Common warts / Warts (viral) / Verruca (morphologic abnormality) / Wart (viral) / Verruca vulgaris (disorder) / Skin papilloma / Papilloma of skin (disorder) / Papilloma of skin / Papilloma skin

IndicationStatusPhase
DBCOND0060939 (Verruca (Warts))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00116675
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric SubjectsTreatment
NCT00114920
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in AdultsTreatment
NCT00116662
An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric SubjectsTreatment
NCT00117871
Study With a Topical Gel to Treat Common Warts in AdultsTreatment
NCT00115141
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in AdultsTreatment
NCT00117923
Study With a Topical Gel to Treat Common Warts in AdultsTreatment